(Sar¹)-Angiotensin II is a stabilized analog used to explore N-terminal structural constraints in angiotensin receptor interactions. Its sarcosine substitution influences backbone flexibility and binding geometry. Researchers use it to evaluate minimal motifs driving signal initiation. The peptide supports high-resolution analysis of angiotensin-family ligands.
CAT No: A15093
CAS No:51833-69-3
Synonyms/Alias:(Sar1)-Angiotensin II;51833-69-3;CHEMBL216061;Sar-Arg-Val-Tyr-Ile-His-Pro-Phe-OH;MFCD00167493;(Sar 1)-Angiotensin II;HY-P3138;BDBM50011973;AKOS040754865;DA-59712;FS108527;MS-31855;CS-0148150;G12437;Sar-Arg-Val-Tyr-Ile-His-Pro-Phe-OH; H-(Sar)RVYIHPF-OH;(Sar1)-Angiotensin II (H-Sar-DL-Arg-L-Val-L-Tyr-L-Ile-L-His-L-Pro-L-Phe-OH);(2S)-2-[[(2S)-1-[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[2-(methylamino)acetyl]amino]pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoic acid;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More